We report the genetic abnormalities in the protein C genes of a Spanish child with neonatal purpura fulminans and disseminated intravascular coagulation, associated with undetectable protein C levels. Direct sequencing of the nine protein C gene exons and their splice junctions indicated that the proband is a compound heterozygote with two mutant protein C gene alleles, Y124C and Q132X, that do not express protein C in plasma. The Y124C mutation was inherited from the mother and is due to a novel A to G transition at nucleotide 3416, which results in the substitution of cysteine for tyrosine 124, a highly conserved amino acid in EGF-like domains. The paternal inherited mutation (Q132X) is a C to T transition at nucleotide 3439, which replaces glutamine 132 with a Stop codon signal. This mutation, if expressed, should result in the synthesis of a truncated protein of 131 amino acids. Y124C or Q132X are present in the heterozygous state in the asymptomatic parents and siblings of the proband, all of which have half the normal plasma levels of protein C. Q123X has also been identified in families where type I PC deficiency is inherited as a clinically dominant trait. Therefore, the presence of the same mutation in a family showing a clinically recessive pattern of inheritance indicates that other factors, apart from the type of protein C gene mutation, are responsible for the clinical expression of protein C deficiency.
References
1
Clouse LH,
Comp PC.
The regulation of haemostasis: the protein C system. New Engl J Med 1986; 314: 1298-1304
2
Greengard JS,
Griffin JH.
Protein C pathways. In: Recent Advances in Haematology.
Hoffbrand AV.
ed Edinburg; UK: Churchill Livingstone: 1988. 5 pp 275-289
4
Bertina RM,
Broekmans AW,
Krommenhoek Es van C,
van Wijngaarden A.
The use of functional and immunologic assay for protein C in the study of heterogeneity of congenital protein C deficiency. Thromb Haemost 1984; 31: 1-5
5
Bovill EG,
Bauer KA,
Dickerman JD,
Callas P,
West B.
The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 1989; 73: 712-717
6
Allaart CF,
Poort SR,
Rosendaal FR,
Rcitsma PH,
Bertina RM,
Briet E.
Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993; 341: 134-138
8
Tuddenham EG D,
Takase T,
Thomas AE,
Awidi AS,
Madanat FF,
Abu Hazir MM,
Kernoff PB,
Hoffbrand AV.
Homozygous protein C deficiency with delayed onset of symptoms at 7 to 10 months. Thromb Res 1989; 53: 475-484
11
Gladson CL,
Scharrer I,
Hach V,
Beck KM,
Griffin JH.
The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 1988; 59: 18-22
14
Reitsma PH,
Bernardi F,
Doig RG,
Gandrille S,
Greengard JS,
Ireland H,
Krawczak M,
Lind B,
Long GL,
Poort SR,
Saito H,
Sala N,
Witt I,
Cooper DN.
Protein C deficiency: A database of mutations, 1995 Update. Thromb Haemost 1995; 73: 876-889
15
Estelles A,
Garcfa-Plaza I,
Dasi A,
Aznar J,
Duart M,
Sanz G,
Perez- Requejo JL,
Espana F,
Jimenez C,
Abeledo G.
Severe inherited “homo zygous” protein C deficiency in a newborn infant. Thromb Haemost 1984; 52: 53-56
16
Garcia Plaza I,
Jimenez Astorga C,
Borrego D,
Marty ML.
Coumarin prophylaxis for fulminant purpura syndrome due lo homozygous protein C deficiency. Lancet 1985; 16: 634
18
Soria JM,
Brito D,
Barceló J,
Fonlcuberta J,
Botero L,
Maldonado J,
Estivill X,
Sala N.
Severe homozygous PC deficiency: Identification of a splice site missense mutation (184șH) in exon 7 of the PC gene. Thromb Haemost 1994; 72: 65-69
19
Spek CA,
Poort SR,
Bertina RM,
Reitsma PH.
Determination of the allelic and haplotype frequencies of three polymorphisms in the promoter region of the human protein C gene. Blood Coagulation and Fibrinolysis 1994; 5: 309-311
20
Reitsma PH,
Poort SR,
Allaart CF,
Briët E,
Bertina R.
The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I; Heterogeneity and founder effects. Blood 1991; 78: 890-894
23
Bertina RM,
Koeleman BP C,
Koster T,
Rosendaal FR,
Dirven RJ,
de Ronde H,
van der Velden PA,
Reitsma PH.
Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
24
Bell IG,
Fong MF,
Stempien MM,
Wormsted MA,
Caput D,
Ku L,
Urdea MS,
Rall LB,
Sanchez Pescador R.
Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucl Acids Res 1986; 14: 8427-8446
25
Koeberl OD,
Bottema CD K,
Ketterling RP,
Bridge PJ,
Lillicrap DP,
Sommer SS.
Mutations causing Hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions and deletions in a human gene. Am J Hum Genet 1990; 47: 202-217
27
Jackman RW.
Human thrombomodulin gene is intron depleted: Nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control. Proc Natl Acad Sci USA 1987; 84: 6425-6429
28
Giannelli F,
Green PM,
High KA,
Sommer S,
Lillicrap DP,
Ludwig M,
Olek K,
Reitsma PH,
Goossens M,
Yoshioka A,
Brownlee GG.
Haemophilia B: Database of point mutations and short additions and deletions-third edition. Nucl Acids Res 1992; 20 suppl 2027-2063
29
Witt I,
Beck S,
Seydewitz HH,
Tasangil C,
Schenck W.
A novel homozygous missense mutation (Val325 → Ala) in the protein C gene causing neonatal purpura fulminans. Blood Coagulation Fibrinolysis 1994; 5: 651-653
30
Long GL,
Tomczak JA,
Rainville IR,
Dreyfus M,
Schramm W,
Schwarz HP.
Homozygous Type I protein C deficiency in two unrelated families exhibiting thrombophilia related to Ala 136 → Pro or Arg286 → His mutations. Tromb Haemost 1994; 72 (04) 526-533
31
Millar DS,
Allgrove J,
Rodeck C,
Kakkar VV,
Cooper DN.
A homozygous deletion/insertion mutation in the protein C (PROC) gene causing neonatal purpura fulminans: prenatal diagnosis in an at-risk pregnancy. Blood Coagulation Fibrinolysis 1994; 5: 647-649
32
Sugahara Y,
Miura O,
Yuen P,
Aoki N.
Protein C deficiency Hong Kong 1 and 2 Hereditary protein C deficiency caused by two mutants alleles, a 5-nucleotide deletion and missense mutation. Blood 1992; 80 (01) 126-133
33
Ido M,
Ohiwa M,
Hayashi T,
Nishioka J,
Hatada T,
Watanabe Y,
Wada H,
Shirakawa S,
Suzuki K.
A compound heterozygous protein C deficiency with a single nucleotide G deletion encoding Gly-381 and an amino acid substitution of Lys for Gla-26. Thromb Haemost 1993; 70: 636-641
34
Matsuda M,
Sugo T,
Sakata Y,
Murayama H,
Mimuro J,
Tanabe S,
Yoshitake S.
A thrombotic state due to an abnormal protein C. N Engl J Med 1988; 319: 1265-1268
36
Grundy CB,
Chisholm M,
Kakkar V,
Cooper DN.
A novel homozygous missense mutation in the protein C (PROC) gene causing recurrent venous thrombosis. Hum Genet 1992; 89: 683-684
37
Conard J,
Horellou MH,
Van Dreden P,
Samama M,
Reitsma PH,
Poort SR,
Bertina RM.
Homozygous protein C deficiency with late onset and recurrent coumarin-induced skin lesions. Lancet 1992; 339: 743-744
38
Yamamoto K,
Matsushita T,
Sugiura I,
Takamatsu J,
Iwasaki E,
Wada H,
Deguchi K,
Shirakawa S,
Saito H.
Homozygous protein C deficiency: identification of a novel missense mutation that causes impaired secretion of the mutant protein C. J Lab Clin Med 1992; 119 (06) 592-593
39
Gandrille S,
Jude B,
Alhenc-Gelas M,
Millaire A,
Aiach M.
Compound heterozygosity in a family with protein C deficiency illustrating the complexity of the underlying molecular mechamism. Thromb Haemost 1993; 70: 747-752
40
Sugahara Y,
Miura O,
Hirosawa S,
Aoki N.
Compound heterozygous protein C deficiency caused by two mutations, Arg-178 to Gin and Cys-331 to Arg, leading to impaired secretion of mutant protein C. Thromb Haemost 1994; 72: 814-818
41
Ido M,
Ohiwa M,
Hayashi T,
Nishioka J,
Hatada T,
Watanabe Y,
Wada H,
Shirakawa S,
Suzuki K.
A compound heterozygous PC deficiency with
a single nucleotide G deletion enconding Gly-381 and an amino acid substitution of Lys for Gla-26. Thromb Haemost 1993; 70: 663-641
42
Yamamoto K,
Tanimoto M,
Emi N,
Matsushita T,
Takamatsu J,
Saito H.
Impaired secretion of elongated mutant of protein C (protein C-Nagoya); molecular and cellular basis for hereditary protein C deficiency. J Clin Invest 1992; 90: 2439-2446
43
Tokugana F,
Wakabayashi S,
Sato H,
Drakawa M,
Tawaraya H,
Koide T.
Identification of one base deletion in exon IX of the Protein C gene that causes a type I deficiency. Thromb Res 1992; 68: 417-423
44
Lind B,
Van Solinge WW,
Schwartz M,
Thorsen S.
Splice site mutation in the human protein C gene associated with venous thrombosis: Demostration of exon skipping by ectopic transcript analysis. Blood 1993; 82: 2423-2432
46
Koeleman BP C,
Reitsma PH,
Allaart CF,
Bertina RM.
Activated protein C resistance as an additional risk factor for thrombosis in protein C deficient families. Blood 1994; 84: 1031-1035
49
Dahlbäck B.
Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995; 85 (03) 607-613
